Regulation of over-the-counter drugs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, first session, June 22, 1979.

Regulation of over-the-counter drugs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, first session, June 22, 1979.

Saved in:

Bibliographic Details
Corporate Author:	United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and Investigations (Author)
Format:	Electronic eBook
Language:	English
Published:	Washington : U.S. Government Printing Office, 1979.
Series:	U.S. Congressional documents. Congressional hearings.
Subjects:	United States. > Food and Drug Administration. Drugs, Nonprescription > United States.
Online Access:	CONNECT

Similar Items

Regulation of over-the-counter (OTC) drugs /
by: Bodie, Agata
Published: (2016)

FDA's prescription to over-the-counter drug switch : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-eighth Congress, first session on the Food and Drug Administration's policies and procedures in switching drugs from prescription to over-the-counter status, June 6, 1983.
Published: (1983)

Over-the-counter drugs : harmless or hazardous? /
by: Sanberg, Paul
Published: (1986)

Modernizing FDA's regulation of over-the-counter drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. September 13, 2017.
Published: (2018)

Modernizing FDA's regulation of over-the-counter drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. September 13, 2017.
Published: (2018)

FDA regulation of over-the-counter (OTC) drugs : overview and issues for Congress /
by: Bodie, Agata
Published: (2021)

Nonprescription drugs : considering a new class for behind-the-counter drugs /
Published: (2010)

Look alike drugs : hearing before the Subcommittee on Crime of the Committee on the Judiciary, House of Representatives, Ninety-seventh Congress, first session on look alike drugs, October 14, 1981.
Published: (1983)

Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018 : report together with additional views (to accompany H.R. 5333) (including cost estimate of the Congressional Budget Office).
Published: (2018)

Tamper-resistant packaging for over-the-counter drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-seventh Congress, second session, October 15, 1982.
Published: (1982)

The legal regulation of sales of over-the-counter cold and allergy medication /
by: Feder, Jody
Published: (2006)

Safety and efficacy of over-the-counter drug use by the elderly : hearing before the Subcommittee on Health and Long-Term Care of the Select Committee on Aging, House of Representatives, Ninety-eighth Congress, first session, July 21, 1983.
Published: (1983)

Safety and efficacy of over-the-counter drug use by the elderly : hearing before the Subcommittee on Health and Long-Term Care of the Select Committee on Aging, House of Representatives, Ninety-eighth Congress, first session, July 21, 1983.
Published: (1984)

Report of the Presiding Officer on proposed trade regulation rule : advertising for over-the-counter drugs : public record 215-51, 16 CFR part 450 /
by: Fitzpatrick, Roger J.
Published: (1978)

Dextromethorphan : pharmacology, clinical uses and health effects /
Published: (2016)

Advertising for over-the-counter antacids : final staff report and recommendations.
Published: (1983)

Cold medications : health care or hype? : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, April 8, 1992.
Published: (1993)

Patient perspectives to self medication : community pharmacy /
by: Debrincat, Michael
Published: (2015)

Impact of limitations on the use of tax-advantaged accounts for the purchase of over-the-counter medication : hearing before the Subcommittee on Oversight of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Twelfth Congress, second session, April 25, 2012.
Published: (2013)

Dietary Supplement and Nonprescription Drug Consumer Protection Act (P.L. 109-462) /
by: Porter, Donna Viola
Published: (2007)

Human resources impact : over-the-counter product packaging safety : hearing before the Committee on Labor and Human Resources, United States Senate, Ninety-ninth Congress, second session on reviewing the effectiveness of current packaging and safety regulations governing over-the-counter products, February 28, 1986.
Published: (1986)

Imitation Controlled Substances Act of 1983 : hearing before the Subcommittee on Alcoholism and Drug Abuse of the Committee on Labor and Human Resources, United States Senate, Ninety-eighth Congresses, first session, on S. 503, to make it unlawful to manufacture, distribute, or possess with intent to distribute, a drug which is an imitation of a controlled substance on a drug which purports to act like a controlled substance, July 14, 1983.
Published: (1983)

Drug regulation reform--oversight. hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session, on food and drug administration regulation of research, development, and marketing of drugs, June 25, 1980.
Published: (1980)

An advertisement of the virtues and use of sundry select and experimented medicines : such whose beneficence is well known to the most eminent physitians /
by: Hammond, Thomas, 17th cent
Published: (1685)

Symptoms in the pharmacy : a guide to the management of common illness /
by: Blenkinsopp, Alison
Published: (2009)

Drugs : many consumers at risk due to poor labeling, lax federal regulation, and a review process that present special problems for the elderly : joint hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business and the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, One Hundred Second Congress, second session, Washington, DC, April 28, 1992.
Published: (1992)

Drug regulation reform--oversight. hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress on how can we best use our limited resources and at the same time insure safe and effective drugs to diseases which occur infrequently.
Published: (1980)

Food and Drug Administration : its programs, problems [and] resources ; prepared for the Interstate and Foreign Commerce Committee, United States House of Representatives /
Published: (1963)

Regulation of new drug R. & D. by the Food and Drug Administration, 1974 : joint hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare, and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-third Congress, second session on examination of new drug research and development by the Food and Drug Administration, September 25 and 27, 1974.
Published: (1975)

Oversight, the Food and Drug Administration's process for approving new drugs : hearings before the Subcommittee on Science, Research, and Technology of the Committee on Science and Technology, U.S. House of Representatives, Ninety-sixth Congress, first session, June 19, 21, July 11, 1979.
Published: (1979)

Food and Drug Administration Act : hearing before the Subcommittee on Public Health and Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-second Congress, second session on H.R. 15315, a bill to strengthen the Food and Drug Administration, and for other purposes, June 9, 1972.
Published: (1972)

Food and Drug Administration (FDA) : overview and issues /
by: Williams, Erin D.
Published: (2008)

How FDA approves drugs and regulates their safety and effectiveness /
by: Bodie, Agata, et al.
Published: (2018)

How FDA approves drugs and regulates their safety and effectiveness.
Published: (2013)

FDA's regulation of the new drug Versed : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, second session, May 5 and 10, 1988.
Published: (1988)

How FDA approves drugs and regulates their safety and effectiveness [June 25, 2012] /
by: Thaul, Susan
Published: (2012)

Food and Drug Administration oversight. hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session.
Published: (1992)

Drug regulation reform--oversight : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session ...
Published: (1980)

FDA's regulation of the new drug Suprol : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, first session, May 27, 1987.
Published: (1988)

The regulation of new drugs by the Food and Drug Administration : the new drug review process : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-seventh Congress, second session, August 3 and 4, 1982.
Published: (1982)